Repligen Corporation (1RGEN)
MTA
Closed
Aug 24, 2026
Day's Range
152.6552 wk Range
96.34Overview - 1RGEN - Repligen Corporation
Key Statistics
Valuation
Enterprise Value
7.38B
P/E (Trailing)
‪246.20‬
PEG Ratio
‪-3.76‬
Price / Sales (TTM)
‪10.97‬
Price / Book
‪4.76‬
EV / EBITDA
‪59.83‬
Profitability
Gross Margin
‪53.90%‬
Profit Margin
‪5.29%‬
Operating Margin
‪9.30%‬
Return on Assets
‪1.39%‬
Return on Equity
‪1.99%‬
Ownership
Shares Outstanding
56.42M
Float
53.47M
Held by Insiders
‪5.24%‬
Held by Institutions
‪120.02%‬
Price stats
Beta
‪1.01‬
50-Day Avg
‪119.58‬
200-Day Avg
‪118.61‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1RGEN - Repligen Corporation
Peers - 1RGEN - Repligen Corporation
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on MTA.
- 1RGENMTARepligen Corporation7.36BMarket Cap+8.22%52-week change249.44P/E (Trailing)‪5.29%‬Profit Margin
- 1ISRGMTAIntuitive Surgical, Inc.179.30BMarket Cap-24.64%52-week change42.30P/E (Trailing)‪28.44%‬Profit Margin
- 1ELMTAEssilorLuxottica125.57BMarket Cap-64.90%52-week change30.51P/E (Trailing)‪8.51%‬Profit Margin
- 1BDXMTABecton, Dickinson and Company53.30BMarket Cap-1.89%52-week change32.92P/E (Trailing)‪4.19%‬Profit Margin
- 1ALCMTAAlcon Inc.34.05BMarket Cap-9.52%52-week change56.11P/E (Trailing)‪5.92%‬Profit Margin
- 1RMDMTAResMed Inc.30.55BMarket Cap-18.50%52-week change23.54P/E (Trailing)‪26.94%‬Profit Margin
- 1SRT3MTASartorius AG Preference Shares18.26BMarket Cap+21.51%52-week change87.21P/E (Trailing)‪5.47%‬Profit Margin
Profile Summary - 1RGEN - Repligen Corporation
About
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems to support the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Headquartered in Waltham, Massachusetts, it serves…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
